Back to Products
FDA 510(k) Cleared

Advanced Ultrasound Wound Therapy with Zero Capital Risk.

Expand your wound care services and accelerate patient healing without the operational headache. The Arobella Qoustic Wound Therapy System™ (QWTS) is available through Kiwi MedGroup with a fixed monthly fee that covers equipment, maintenance, and comprehensive compliance support.

Arobella Qoustic Wound Therapy System on rolling cart with integrated IV fluid delivery

Trusted by Leading Institutions

Mayo ClinicWalter Reed NMMCJohns HopkinsDuke UniversityBaylor Scott & White
Clinical Evidence

Why It Works

The science behind the QWTS — engineered at the optimal frequency for superior wound outcomes.

The 35 kHz Sweet Spot

The QWTS is the only device in its class operating at 35 kHz — clinically recognized as the optimal frequency for bioburden control and bactericidal effect.

Superior Biofilm Control

Creates a stable cavitation field that gently separates necrotic tissue and reduces biofilm bacteria, successfully eliminating planktonic bacteria including MRSA, Pseudomonas aeruginosa, and Staphylococcus aureus.

Patented Fluid Wash & Versatility

An integrated fluid wash system maximizes ultrasound delivery across the wound. The dome-shaped Qoustic Qurette allows for both contact-based sharp debridement and non-contact therapy from a single handpiece.

Patient Comfort

Patients regularly report significant pain reduction starting at their very first session.

Graft Preparation

The only ultrasound wound therapy device holding an FDA indication specifically for graft bed preparation.

Safety & Speed

Produces less aerosolization and splatter than competitors. Most wounds under 100 cm² can be treated in under 3 minutes.

Ultrasonic cavitation mechanism diagram showing 35 kHz waves creating cavitation bubbles 1-2cm above the wound surface

Non-contact cavitation therapy — 35 kHz ultrasonic waves at 1–2 cm from wound surface

Business Case

Built for Your Bottom Line

Zero capital risk, full reimbursement support, and a turnkey launch package.

$0 Upfront

Flexible ownership and lease options through Kiwi MedGroup with a fixed monthly fee covering equipment, maintenance, and compliance support.

Full Reimbursement

Covered by most major insurance plans and billable per session under CPT codes 97610, 11042–11047, and 97597–97598.

Turnkey Launch

Complete Practice Launch Package including hands-on QWTS Certification training, patient eligibility verification, and billing guidance.

Unmatched Pedigree

FDA 510(k) cleared (K131096). Trusted by Mayo Clinic, Walter Reed, Johns Hopkins, Duke University, and Baylor Scott & White.

Billable CPT Codes

Covered by most major insurance plans — billable per session

976101104211043110441104511046110479759797598
Clinical Proof

Documented Outcomes

Real-world clinical progressions demonstrating the efficacy of ultrasonic wound therapy.

Clinical evidence demonstrates the QWTS system's role in successful limb salvage cases, with documented tissue granulation improvement and wound closure progression over a series of treatments. Multiple case studies confirm statistically significant limb preservation rates when the QWTS is integrated into a comprehensive wound care protocol.

Pre- and post-treatment imaging confirms effective biofilm disruption and removal through ultrasonic cavitation at 35 kHz. Studies show a >99.9% reduction in planktonic bacteria including MRSA within a single treatment session, with sustained bioburden control across multi-session treatment plans.

As the only ultrasound device with an FDA indication for graft bed preparation, the QWTS has demonstrated superior wound bed conditioning resulting in improved graft take rates. Clinical data shows enhanced vascularity and granulation tissue formation in prepared wound beds.

Specifications

Technical Overview

Frequency
35 kHz (±5%)
FDA Status
510(k) Cleared — K131096
Modalities
Contact debridement & non-contact therapy
Fluid Delivery
Integrated saline wash system
Treatment Time
< 3 minutes for wounds under 100 cm²
Handpiece
Dome-shaped Qoustic Qurette™
FDA Indications
Wound debridement, graft bed preparation
Availability
$0 upfront — fixed monthly through Kiwi MedGroup
Training & Education

Master the QWTS System

Comprehensive video training to ensure your team is confident and certified from day one.

Full Training Overview

Complete walkthrough of setup, operation, and best practices for the Qoustic Wound Therapy System.

Contact Technique

Learn the contact-based sharp debridement method using the Qoustic Qurette™ handpiece.

Non-Contact Technique

Master the non-contact ultrasonic cavitation therapy for gentle biofilm disruption and wound bed preparation.

Clinical Resources

Product Documentation

Access brochures, regulatory documentation, and clinical references for the QWTS system.

Unlock Clinical Resources

Complete the form below to instantly access all product documentation.

QWTS System Brochure

Complete product overview, clinical benefits, and technical specifications.

CMS LCD Information

Medicare Local Coverage Determination details for reimbursement guidance.

FDA 510(k) Certificate

Official FDA clearance documentation (K131096) for regulatory compliance.

Instructions for Use (IFU)

Detailed usage instructions, safety information, and procedural guidance.

Ready to Add Ultrasound Wound Therapy?

Get the Arobella QWTS in your clinic with $0 upfront investment. Our team handles training, compliance, and billing support so you can focus on patient outcomes.

Schedule a Consultation Call (949) 200-3087